Frontiers in Oncology | Pediatric Oncology

Original Research

Published on 02 Feb 2024

Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside

in Pediatric Oncology

Illya Martynov
Lajwanti Dhaka
Benedikt Wilke
Paul Hoyer
M. Reza Vahdad
Guido Seitz

Frontiers in Oncology

doi 10.3389/fonc.2024.1333129

2,619 views
1 citation

Brief Research Report

Published on 31 Jan 2024

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells

in Pediatric Oncology

Anna Josefine von Ofen
Uwe Thiel
Jennifer Eck
Hendrik Gassmann
Melanie Thiede
Julia Hauer
Per Sonne Holm
Sebastian J. Schober

Frontiers in Oncology

doi 10.3389/fonc.2024.1304374

2,807 views

Original Research

Published on 31 Jan 2024

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden

in Pediatric Oncology

Sofia Wallin
Ingrid Øra
Gabriela Prochazka
Johanna Sandgren
Caroline Björklund
Gustaf Ljungman
Hartmut Vogt
Torben Ek
Cornelis M. van Tilburg
Anna Nilsson

Frontiers in Oncology

doi 10.3389/fonc.2024.1340099

1,785 views

Clinical Trial

Published on 31 Jan 2024

PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults

in Pediatric Oncology

Nicola Fenwick
Rebekah Weston
Keith Wheatley
Jodie Hodgson
Lynley Marshall
Martin Elliott
Guy Makin
Antony Ng
Bernadette Brennan
Stephen Lowis

Frontiers in Oncology

doi 10.3389/fonc.2024.1296576

2,391 views
6 citations

Case Report

Published on 29 Jan 2024

Diffuse infantile hepatic hemangioma successfully treated with propranolol orally: a case report and literature review

in Pediatric Oncology

Zengyan Li
Zhiming Wu
Youhong Dong
Xiaojun Yuan
Dongdong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1336742

1,658 views

Mini Review

Published on 19 Jan 2024

Mast cell in infantile hemangioma

in Pediatric Oncology

Meng Xia
Wenying Liu
Fang Hou

Frontiers in Oncology

doi 10.3389/fonc.2024.1304478

1,949 views
2 citations

Original Research

Published on 17 Jan 2024

Prognostic factors of pediatric ependymomas at a National Cancer Reference Center in Peru

in Pediatric Oncology

Eduardo Perez-Roca
Tatiana Negreiros
Sandro Casavilca-Zambrano
Luis Ojeda-Medina
Rosdali Díaz-Coronado

Frontiers in Oncology

doi 10.3389/fonc.2023.1331790

1,624 views

Case Report

Published on 08 Jan 2024

Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

in Pediatric Oncology

Francesco Fabozzi
Rosalba Carrozzo
Mariachiara Lodi
Angela Di Giannatale
Selene Cipri
Chiara Rosignoli
Isabella Giovannoni
Alessandra Stracuzzi
Teresa Rizza
Claudio Montante

Frontiers in Oncology

doi 10.3389/fonc.2023.1324013

1,975 views
1 citation

Case Report

Published on 20 Dec 2023

Case report: Primary pleural low-grade fibromyxoid sarcoma in a 4-year-old boy with molecular confirmation

in Pediatric Oncology

Xiangni He
Wenyi Jing
Xin He
Min Chen
Hongying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1269078

1,669 views
1 citation

Editorial

Published on 14 Dec 2023

Editorial: Pediatric diencephalic tumors: a constellation of entities and management modalities

in Pediatric Oncology

Antonella Cacchione
Andrea Carai
Veronica Biassoni
Angela Mastronuzzi
Sabina Vennarini

Frontiers in Oncology

doi 10.3389/fonc.2023.1346803

885 views

Original Research

Published on 11 Dec 2023

Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer

in Pediatric Oncology

Daniel V. Runco
Linda A. DiMeglio
Charles P. Vanderpool
Yan Han
Joanne Daggy
Mary M. Kelley
Raya Mikesell
Teresa A. Zimmers

Frontiers in Oncology

doi 10.3389/fonc.2023.1295228

3,422 views
3 citations

Mini Review

Published on 07 Dec 2023

Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases

in Pediatric Oncology

Selene Cipri
Francesco Fabozzi
Giada Del Baldo
Giuseppe Maria Milano
Luigi Boccuto
Andrea Carai
Angela Mastronuzzi

Frontiers in Oncology

doi 10.3389/fonc.2023.1235794

1,682 views

Case Report

Published on 29 Nov 2023

Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy

in Pediatric Oncology

Federica D’Antonio
Sabrina Rossi
Isabella Giovannoni
Rita Alaggio
Andrea Carai
Giuseppe M. Milano
Antonella Cacchione
Alessandra Cancellieri
Marco Gessi
Manila Antonelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1203994

3,280 views
2 citations

Correction

Published on 27 Nov 2023

Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

in Pediatric Oncology

Ema Mosleh
Stacy Snyder
Ningying Wu
Daniel N. Willis
Rema Malone
Robert J. Hayashi

Frontiers in Oncology

doi 10.3389/fonc.2023.1333273

859 views

Original Research

Published on 02 Nov 2023

PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case–control study

in Pediatric Oncology

Wenjiao Ding
Dao Wang
Mansi Cai
Yaping Yan
Shanshan Liu
Xiaodan Liu
Ailing Luo
Decheng Deng
Xiaoping Liu
Hua Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1203002

1,592 views
2 citations

Case Report

Published on 01 Nov 2023

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia

in Pediatric Oncology

Sumit Gupta
Jessica Casey
Joseph Lasky

Frontiers in Oncology

doi 10.3389/fonc.2023.1246924

4,645 views
2 citations